Clinical Trial Update: Glucose Reduction by Early Acarbose Treatment in Basal Insulin [Phase 4]

View source ↗

Summary

A Phase 4 trial update reports that initiating acarbose early in patients with type 2 diabetes on basal insulin improves glucose control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)

Snippet

Sponsor: Bayer | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED